The MarketWatch News Department was not involved in the creation of this content.-- The company appoints Joel Parker, Ph.D., as Chief Scientific Officer; Ana Vivancos, Ph.D., as D ...
This report explores privacy and anonymity in the context of genetic and genomic data: the protection of privacy and anonymity is regarded by some as of absolute importance, but increasingly, this ...
Much like software and data analytics reshaped industries like finance and retail, a similar transformation is now creating a new landscape for investors in medicine. Genomics stands at the forefront ...
ConcertAI, a leading oncology real-world evidence data and AI SaaS technology company, and Foundation Medicine, a global, patient-focused precision medicine company, today announced a collaboration to ...
MEGI unifies IS, ICE, transposon and phage annotations into the first comprehensive mobile-element dataset, boosting Centroid ...
In the face of climate change, apple breeding programs need innovative ways to select cultivars that can thrive under diverse conditions. A recent study demonstrates how integrating genomic data with ...
GeneDx leverages a vast rare disease database and advanced genomic testing, offering superior insights over traditional panel testing. The company achieved a significant turnaround, becoming cash flow ...
In an effort to foster progress in cancer research, the National Institute of Standards and Technology (NIST) is releasing detailed and comprehensive data about the entire genetic content of a ...
Fujitsu Laboratories Ltd. announced the development of a technology that accelerates database analyses of the correlations between genomic variations and environmental information, such as disease and ...
As cancer care increasingly shifts toward data-driven decision-making, 4baseCare is positioning itself at the intersection of genomics, AI, and clinical practice.The Bengaluru-based precision oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results